SCHEMBL7698769

SCHEMBL7698769

O=C(NCc1ccccc1)Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.58
CHEK1 O14757 6/20 0.56
NAMPT P43490 3/20 0.53
CDK2 P24941 2/20 0.52
CDK1 P06493 1/20 0.52
ROCK2 O75116 2/20 0.51
ROCK1 Q13464 1/20 0.51
SGK1 O00141 1/20 0.49
CHEK2 O96017 1/20 0.49
PRKCG P05129 1/20 0.49
AKT1 P31749 1/20 0.49
AKT2 P31751 1/20 0.49
MARK2 Q7KZI7 1/20 0.49
AKT3 Q9Y243 1/20 0.49
KIT P10721 2/20 0.48
CCNE2 O96020 1/20 0.48
CDK4 P11802 1/20 0.48
CCND1 P24385 1/20 0.48
CCNE1 P24864 1/20 0.48
FLT1 P17948 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701855 0.93 NAMPT (0.64) KDRCHEK1NAMPTCDK2CDK1
SCHEMBL7701559 0.91 NAMPT (0.52) KDRCHEK1NAMPTCDK2CDK1
SCHEMBL7701963 0.87 CHEK1 (0.57) KDRCHEK1CDK2CDK1KCNH2
SCHEMBL7705692 0.86 CHEK1 (0.62) KDRCHEK1CDK2CDK1KIT
SCHEMBL7701135 0.86 KMT2A (0.53) CHEK1
SCHEMBL7702362 0.85 KDR (0.52) KDRCHEK1NAMPTCDK2CDK1
SCHEMBL7705309 0.85 KDR (0.69) KDRCHEK1NAMPTCDK2CDK1
SCHEMBL7701122 0.83 CHEK1 (0.48) KDRCHEK1NAMPTCDK2CDK1
SCHEMBL7701166 0.83 CHEK1 (0.53) KDRCHEK1CDK2CDK1KCNH2
SCHEMBL7091508 0.82 KDR (0.56) KDRCHEK1CDK2CDK1SGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed